Welcome to PMK-Ventures

At PMK-Ventures, we are dedicated to fueling innovation in the Biotech and MedTech sectors. Based in Singapore, our mission is to invest in and empower small, cutting-edge companies around the globe, driving advancements that shape the future of healthcare.

We understand that the most challenging phase in the lifecycle of a Biotech or MedTech company is navigating the clinical research and development (R&D) stage, particularly reaching a successful exit point. The journey from concept to clinical trial success is fraught with obstacles, and the statistics are daunting. The costs associated with clinical trials can run into hundreds of millions of dollars, making it critical to have the right strategic partners to mitigate risks and maximize success.*

At PMK-Ventures, we offer tailored solutions to help companies overcome these hurdles, ensuring that innovative treatments and technologies have the best possible chance of reaching patients in need. By providing financial support, industry expertise, and strategic guidance, we aim to be the catalyst that drives these companies toward successful exits, transforming promising research into real-world impact.

Together, we can turn visionary ideas into transformative realities.

By partnering with PMK-Ventures, companies gain access to the resources and expertise necessary to navigate these challenges, enhancing their potential for success.

*Impact of Clinical Trials on Biotech and MedTech Companies

Low Success Rates: Historically, only about 1 in 10 drug candidates that enter clinical trials are eventually approved by the FDA, underscoring the significant challenge of this stage.

High Costs: The average cost of bringing a new drug to market, including the cost of failed trials, can exceed $2.6 billion .

Lengthy Process:The average time from preclinical trials to market approval can span 10 to 15 years, further emphasizing the need for efficient and effective clinical trial strategies.